Fhit loss in lung preneoplasia: Relation to DNA damage response checkpoint activation
Received 1 September 2009; received in revised form 21 October 2009; accepted 22 October 2009. published online 20 November 2009.
Abstract
Loss of heterozygosity at the FHIT locus is coincident with activation of DNA damage response checkpoint proteins; thus damage at fragile loci may trigger checkpoint activation. We examined preneoplastic lesions adjacent to non-small cell lung carcinomas for alterations to expression of Fhit and activated checkpoint proteins. Expression scores were analyzed for pair-wise associations and correlations among proteins and type of lesion. Hyperplastic and dysplastic lesions were positive for nuclear γH2AX expression; 12/20 dysplastic lesions were negative for Fhit expression. Fhit positive lesions showed expression of most checkpoint proteins examined, while Fhit negative lesions showed absence of expression of Chk1 and phosphoChk1. The results show that loss of expression of Fhit is significantly directly correlated with absence of activated Chk1 in dysplasia, and suggest a connection between loss of Fhit and modulation of checkpoint activity.
aDivision of Pathology, II University of Rome “La Sapienza”, Ospedale Santo Andrea, Rome, Italy
bDivision of Pathology, Ospedale San Camillo Forlanini, Rome, Italy
cDepartment of Molecular Virology, Immunology and Medical Genetics and Comprehensive Cancer Center, Ohio State University, OH, USA
Corresponding authors. Addresses: Ohio State University Comprehensive Cancer Center, Biomedical Research Tower, Rm 916, 460W. 12th Ave., Columbus, OH 43210, USA. Tel.: +1 614 292 4850; fax: +1 614 688 8675 (K. Huebner). Division of Pathology, II University of Rome “La Sapienza”, Ospedale Santo Andrea, Rome, Italy (A. Vecchione).